ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 266

Cardiovascular Disease In Osteoarthritis: Hip Versus Knee and The Influence Of Multiple Symptomatic Joint Involvement

Anthony V. Perruccio1, Rita A. Kandel2 and Aileen M. Davis3, 1Toronto Western Hospital, Toronto Western Research Institute, and University of Toronto, Toronto, ON, Canada, 2Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 3Health Care and Outcomes Research, Toronto Western Research Institute; Departments of Rehabilitation Science and Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Hip, Knee, osteoarthritis and polyarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Risk Factors for and Sequelae of Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: The strength of association between obesity and osteoarthritis (OA) is reported to vary by joint (e.g. stronger association with knee than hip). As well, the association between obesity and non weight-bearing joints, such as the hands, suggests that systemic/metabolic factors are involved. The presence of multiple symptomatic joints among individuals with severe OA in at least one joint further suggests likely systemic factors in OA. Given known associations between systemic/metabolic factors and cardiovascular disease (CVD) risk, this study investigated the likelihood of reporting CVD between those with hip vs. knee OA, and further considered if the number of symptomatic joints influenced this likelihood.

Methods: Patients with severe OA (443 hip; 540 knee) reported CVD, diabetes, high blood pressure (HBP), symptomatic joints, height, weight, age and sex. The cross-sectional association between study measures and prevalent CVD was investigated using logistic regression, with the inclusion of an interaction term between symptomatic joint count and knee/hip group membership. Subsequently, the analysis was stratified by knee/hip.

Results: Knee: ages 41-88 years, 64% female, 4% CVD, 14% diabetes, 50% HBP. Hip: ages 40-91 years, 55% female, 5% CVD, 9% diabetes, 43% HBP. Mean joint count was 5 (±4), ranging from 1-20.  Adjusted for age, sex, body mass index, and presence of diabetes or HBP, the knee cohort had odds 4 times greater than hips for reporting CVD (p<0.01). There was a significant interaction between joint count and knee/hip group status, such that the effect of increasing joint count was greater for the hip cohort. From stratified analyses, joint count was associated with CVD in the hip cohort only, with a 25% increased odds with each numerical increase in symptomatic joint count (odds ratio (OR): 1.25, p<0.001). In the knee cohort, the presence of diabetes or HBP was significantly associated with reporting CVD (OR: 3.74, p=0.02), whereas a similar association was not found in the hip cohort (OR: 1.23, p=0.68).

Conclusion: The variable association observed with CVD between hip and knee OA, alongside the differential influence of the extent of symptomatic joint involvement between joint groups suggests different OA phenotypes, with potentially varying roles for systemic factors. This has potential implications for our understanding of OA, and suggests a potential need for multimodal approaches to treatment and management.


Disclosure:

A. V. Perruccio,
None;

R. A. Kandel,
None;

A. M. Davis,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-disease-in-osteoarthritis-hip-versus-knee-and-the-influence-of-multiple-symptomatic-joint-involvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology